Product
Phase 2; Placebo
1 clinical trial
6 indications
Indication
SpasticityIndication
StrokeIndication
Multiple SclerosisIndication
Traumatic Brain InjuryIndication
Spinal Cord InjuryIndication
Cerebral PalsyClinical trial
Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Treatment Efficacy and Safety Study of MYOBLOC in Treatment of Adult Upper Limb Spasticity and Open-Label Extension, Multiple-Treatment Safety Study of MYOBLOCStatus: Active (not recruiting), Estimated PCD: 2023-07-01